Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia Subgroup Analysis of the Green Study | AVESİS

Lokman Hekim Üniversitesi Akademik Veri Yönetim Sistemi

Safety and Efficacy of Obinutuzumab Plus Bendamustine in Previously Untreated Patients with Chronic Lymphocytic Leukemia Subgroup Analysis of the Green Study

Atıf İçin Kopyala

blood journal, 3 - 05 Aralık 2015

Yayın Türü: Bildiri
Lokman Hekim Üniversitesi Adresli: Evet